Medical Middle Market Sale 
Sun Acquisitions
FEBRUARY 26, 2024
Business photo created by rawpixel.com – www.freepik.com CHICAGO, IL – February 23, 2024 – A distinguished specialty plastics provider for medical devices out of Northern California, has initiated a sell-side engagement represented by Sun Acquisitions.
Align Business Advisory Services
SEPTEMBER 28, 2023
As M&A (Mergers and Acquisitions) specialists in the lower-middle market ($10 million to $200 million in annual sales), we always counsel our clients to plan ahead for an exit from their business or medical practice. Read More » The post Climbing Your Second Mountain appeared first on Align BA.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Periculum Capital
MAY 14, 2024
Periculum Capital Company, LLC is pleased to announce it has advised Micro-Dyn Medical Systems, Inc., About Periculum Capital Company, LLC Periculum is a leading investment and merchant banking firm serving the corporate finance needs of middle market companies.
Focus Investment Banking
NOVEMBER 30, 2023
They are among the most active advisors to medical professionals in transactions with private equity-backed organizations. “We Download this press release as a PDF The post FOCUS Investment Banking Represents Michigan ENT & Allergy Specialists in its sale to Parallel ENT & Allergy appeared first on FOCUS Investment Banking LLC.
Focus Investment Banking
AUGUST 15, 2023
Washington, DC, (August 15, 2023) – FOCUS Investment Banking (“FOCUS”), a national middle market investment banking firm providing merger, acquisition, divestiture and corporate finance services, announced today that it has added two new managing directors, Mike McCraw and William R. Bill”) Snow.
Tyton Partners
APRIL 10, 2024
Excolere Equity Partners is a leading middle market private equity firm that leverages its deep sector experience and strategic and operational expertise to accelerate the growth and enhance the impact of companies in the Education and Human Capital sector.
Mergers and Inquisitions
NOVEMBER 1, 2023
The short answer to #1 is that healthcare private equity firms operate in specific verticals with stable-ish cash flows, such as healthcare services, nursing facilities, medical devices, equipment, and healthcare IT. At the time of the deal, it was expected to grow sales at 3-5%: Remember that PE deals do not require “growth.”
Expert insights. Personalized for you.
52 
Let's personalize your content